Clinical Trial Update: CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update on CD22-directed CAR T cells for children and young adults with B-cell malignancies, including B-cell lymphoma and pedia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Lymphoma
• Lymphoma

Drugs mentioned

• CD22-CAR T Cells

Snippet

Sponsor: Stanford University | Conditions: B Cell Lymphoma, Acute Lymphoblastic Leukemia, Pediatric | Phase 1 | Status: ACTIVE_NOT_RECRUITING